Your browser doesn't support javascript.
loading
Kidney transplantation with organs from donors after circulatory death type 3: a prospective multicentric Spanish study (GEODAS 3).
Portolés Pérez, J; Lafuente, O; Sánchez-Sobrino, B; Pérez Sáez, M J; Fernández García, A; Llamas, F; López-Sánchez, P; Rodriguez-Ferrero, M L; Zarraga, S; Ramos, A; Pascual, J.
Afiliação
  • Portolés Pérez J; Nephrology Department, Hospital Universitario Puerta de Hierro, Majadahonda, Spain. Electronic address: josem.portoles@salud.madrid.org.
  • Lafuente O; Nephrology Department, Hospital Universitario Puerta de Hierro, Majadahonda, Spain.
  • Sánchez-Sobrino B; Nephrology Department, Hospital Universitario Puerta de Hierro, Majadahonda, Spain.
  • Pérez Sáez MJ; Nephrology Department, Hospital del Mar, Parc de salut Mar, Barcelona, Spain.
  • Fernández García A; Nephrology Department, Hospital Universitario de A Coruña, A Coruña, Spain.
  • Llamas F; Nephrology Department, Complejo H. Universitario de Albacete, Albacete, Spain.
  • López-Sánchez P; Nephrology Department, Hospital Universitario Puerta de Hierro, Majadahonda, Spain.
  • Rodriguez-Ferrero ML; Nephrology Department, Hospital Universitario Gregorio Marañón, Madrid, Spain.
  • Zarraga S; Nephrology Department, Hospital Universitario Cruces, Bilbao, Spain.
  • Ramos A; Nephrology Department, Fundación Jimenez Díaz, Madrid, Spain.
  • Pascual J; Nephrology Department, Hospital del Mar, Parc de salut Mar, Barcelona, Spain.
Transplant Proc ; 47(1): 27-9, 2015.
Article em En | MEDLINE | ID: mdl-25645762
ABSTRACT
To increase the number of kidney donors, new strategies are needed such as living donor programs, expanded criteria donors, or donors after circulatory death (DCD) kidney transplantation programs. The GEODAS group has started an observational, prospective, multicenter clinical study, collecting data from all DCD type-3 kidney transplantations performed in seven Spanish hospitals from January 2012 to January 2014. The preliminary results have shown a delayed graft function of 40.4% and graft survival of 93.7% with a nadir creatinine of 1.3 mg/dL. From all 33 potential donors included in the study, 32 were effective and 63 kidney grafts were transplanted with a utilization rate of 98.5%. Creatinine evolution (median [range]) was in the first month 2.1 [0.6-5.6]; third month 1.6 [0.8, 4.2]; first year 1.6 [0.9-2.2]. These results are similar to kidney transplantation from donors after brain death as shown in the literature, especially in the graft and recipient survival rates. In addition, the controlled programs are easier and less expensive than uncontrolled DCD programs with a higher rate of graft use.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Choque / Transplante de Rim / Morte / Seleção do Doador / Falência Renal Crônica Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País como assunto: Europa Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Choque / Transplante de Rim / Morte / Seleção do Doador / Falência Renal Crônica Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País como assunto: Europa Idioma: En Ano de publicação: 2015 Tipo de documento: Article